Purified preparations of herpes simplex virus type 1 Angelotti were digested with the exoglycosidases sialidase, fl-galactosidase, N-acetyl-fl-D-glucosaminidase and a-mannosidase, and with the endoglycosidases Endo-H and Endo-F. It was found that treatment of virions with Endo-F specifically decreased viral infectivity by a factor of 10. This reduction in titre was not associated with any measurable differences in virus adsorption, suggesting a role of N-linked complex type oligosaccharide chains in penetration. In contrast, a reduction in titre observed upon digestion of virions with exoglycosidases could be attributed to a proteolytic contamination in these enzyme preparations. Treatment of virions with Endo-H, demonstrated to be free of proteolytic contamination, did not reduce viral infectivity. Analysis of endoglycosidase-digested virions by monospecific antibodies and immunoblotting revealed a susceptibility of all four major glycoproteins (gC, gB, gE and gD) to Endo-F, but only gB was susceptible to Endo-H treatment. In contrast, of all the exoglycosidases used only sialidase was found to be active towards native viral glycoproteins. Upon analysis of endoglycosidasedigested virions we could not find any evidence for proteolysis, degradation or altered protein composition of viral envelopes. In contrast, vigorous inhibition of glycoprotein glycosylation by tunicamycin led to the formation of physically intact virions almost completely lacking all major glycoproteins. These data show that digestion of intact virions with glycosidases allows an analysis of the functional relevance of carbohydrate residues without any obvious alterations in the virion glycoprotein composition.
INTRODUCTION
In previous studies the effect of glycoprotein glycosylation on viral infectivity has been investigated by the use of various glycosylation inhibitors and by analysis of virions grown in cell lines defective in the processing of oligosaccharide chains (summarized by Spear, 1984) . Using Ric-14 and Ric-21 cells, which are deficient in N-acetyl-fl-D-glucosaminyl transferase I and in the addition of terminal carbohydrates to N-linked glycans respectively, Campadelli-Fiume et al. (1982) and Serafini-Cessi et al. (1983) showed that complex type glycans are apparently not required for infectivity. Similar results were obtained (Johnson & Spear, 1982; GhoshChoudhury et al., 1987; Kousoulas et al., 1983a) using monensin as an inhibitor of glycoprotein processing. Also, the presence of underglycosylated proteins in virions caused by ammonium chloride treatment of virus-infected cells did not result in an obvious decrease of viral infectivity (Kousoulas et al., 1983b) .
In contrast, glycosylation inhibition by 2-deoxy-D-glucose (Spivack et al., 1982) or tunicamycin (Svennerholm et al., 1982; Pizer et al., 1980; Katz et al., 1980; Kousoulas et al., 1983 b) led to a highly significant reduction in viral infectivity. This loss of infectivity, however, was found to be associated with an almost complete lack of glycoproteins in the envelopes of 0000-8374 © 1988 SGM j.E. KUHN AND OTHERS physically intact virions isolated from cell lysates (Kousoulas et al., 1983b; Peake et al., 1982) .
Further experiments with tunicamycin-modified virions revealed an inhibition of the infectious process at a stage subsequent to adsorption, probably penetration (Svennerholm et al., 1982) . This was also observed when 2-deoxy-n-glucose was used as a glycosylation inhibitor (Spivack et al., 1982) .
Taking into consideration that the use of glycosylation inhibitors leads to alterations in the glycoprotein composition of viral envelopes (Kousoulas et al., 1983 b; Peake et al., 1982) , it is not possible to draw firm conclusions on the specific role of carbohydrate residues in infectivity. On the other hand the use of mutant cell lines, such as Ric-14 and Ric-21 which are deficient in certain stages of oligosaccharide processing, is a valuable means of studying glycoprotein processing and function (Meager et al., 1976; Vischer & Hughes, 1981) . This system, however, allows only limited modification of glycoprotein glycosylation. In an attempt to elucidate further the relevance of glycoprotein glycosylation for the infectivity of herpes simplex virus type t (HSV-1) we have used the approach of digesting purified virions with various exo-and endoglycosidases and have shown that removal of N-linked oligosaccharides leads to a decrease in infectivity, attributable to a stage following adsorption.
METHODS
Virus and viral growth. For preparation of virus stocks African green monkey kidney (RC-37) cells were used.
Cells were held in Basal Medium Eagle (BME) containing 10~ foetal calf serum (FCS), 100 units (U)/ml penicillin, 100 Ixg/ml streptomycin, and were grown at 37 °C in a humidified atmosphere containing 5~o CO2. HSV-1 Angelotti (HSV-1 Ang) (Munk & Ludwig, 1972) was used throughout. Viral stocks were prepared by three passages at low m.o.i, to avoid formation of defective and defective interfering particles, followed by one passage at an m.o.i, of 3 p.f,u./cell. Viral titres were determined by plaque assay as described previously (Braun et aL, 1984) . Lysates of HSV-l-infected cells were prepared by infecting RC-37 cells at an m.o.i, of 5 p.f.u./cell. Cells were washed 1 h post-infection (p.i.) and maintained in BME supplemented with 5~ FCS for 40 b. Cells were harvested by gentle agitation with glass beads, washed twice in Tris-buffered saline (TBS; 50 mM-Tris HC1 and 150 mM-NaCI) pH 7.4, containing 1 mM-PMSF (Sigma), and finally disrupted by repeated freezing and thawing and extensive sonication. Cell lysates were stored at -70 °C. For preparation of virus grown under tunicamycin, infected cells were held in medium with 2.5 ~tg/ml tunicamycin (Boehringer Mannheim).
Purified virions were obtained as described previously (Spear & Roizman, 1972) . Briefly, cells were infected at an m.o.i, of 5 p.f.u./cell. Cells were washed thoroughly 1 h p.i. to remove non-adsorbed virus and re-fed with fresh BME containing 5~ FCS. Supernatants from infected cell cultures were collected 36 h p.i. and clarified by low speed centrifugation at 3000 g for 20 rain. Virions were pelleted by high speed centrifugation at 100000 g for 60 min in an SW27 rotor (Beckman), resuspended in a small volume of TBS pH 7-4 and subjected to centrifugation on a linear 30 to 70~ sucrose gradient. Upon centrifugation at 100000 g for 90 min at 4 °C in an SW41 rotor (Beckman) virions formed a visible band at 45 to 50~ sucrose. Virions were isolated from the gradients, resuspended in TBS and centrifuged once more at 100000 g for 60 min in an SW41 rotor. The final pellet was resuspended in TBS containing 1 mM-PMSF.
To obtain [3H]thymidine-labelled virus, RC-37 cells were infected with HSV-1 Ang at an m.o.i, of 5 p.f.u./cell. [3H]Thymidine (Amersham Buchler) was added 2 h p.i. to a final concentration of 20 ~tCi/ml. [3H]Thymidinelabelled purified virions were obtained as described above.
Enzymic deglycosylation ofvirions. The endoglycosidases Endo-H (E.C. 3.2.1.96, from Streptomyces plicatum) and Endo-F (E.C. 3.2.1.96, from Elavobacterium meningosepticum) were purchased from Boehringer Mannheim.
The protein concentration of enzyme preparations was approx. 8 mg/ml in 20 raM-potassium phosphate buffer pH 7-2 containing 50 mM-EDTA (Endo-F) or 20 mM-potassium phosphate buffer pH 8.5 containing 50 mM-EDTA (Endo-H). Stock solutions of enzymes were stored in 10 ~tl aliquots at -70 °C until use. Deglycosylation of intact virions by endoglycosidases was performed as follows. Virus suspension (25 ~tl) containing 2 x 109 p.f.u./ml HSV-1 Ang was mixed with 2 ~tl of endoglycosidase stock solution (or mock solution) and 8 ~tl of TBS pH 7-4. In order to adjust the pH of the reaction mixture to 6.0, 10 itl of sterile 0.175 M-sodium phosphate buffer pH 5.1 was added. The final enzyme concentration was 0.4 mg/ml. Samples were incubated for 18 h at 37 °C. Subsequently, the reaction mixture was brought to 1 ml with BME and the remaining infectivity was determined in comparison to mock-treated virions, to which the enzymes had been added after completion of the incubation period.
The exoglycosidases sialidase (E.C. 3.2.1.18, from Clostridium perfringens), c~-mannosidase (E.C. 3.2.1.24, from Canavalia ensiformis), fl-galactosidase (E.C. 3.2.1.23, from Escherichia coli) and N-acetyl-fl-D-glucosaminidase (E.C. 3.2.1.30, from bovine kidney) were purchased from Boehringer Mannheim. Sialidase was solubilized in 175 mM-sodium phosphate buffer (pH 5.1 ; protein content 1 mg/ml), the other three enzymes were supplied in 3.2 M-ammonium sulphate pH 6.0 (protein content 5 mg/ml). 
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Digestion of virions with exoglycosidases was performed as follows. The enzyme stock suspensions in ammonium sulphate buffer were pelleted at 10000g for 5 rain and enzymes were diluted in an equal volume of TBS pH 7-4. For sialidase digestion the enzyme stock solution was used directly. Sialidase solution (8 ~1) was mixed with 0.5 pl/~-galactosidase, 1 p.1 N-acetyl-/~-D-glucosaminidase, and 0.5 p.l ~-mannosidase. In control experiments with mock-digested virions, enzymes were replaced by appropriate amounts of TBS. Subsequently, 10 i11 TBS and 25 ~1 gradient-purified virions (containing 2 × 109 p.f.u./ml) were added to this enzyme mixture. The final enzyme concentrations were as follows: sialidase 0.18 mg/ml,/~-galactosidase 0.06 mg/ml, N-acetyl-/3-D-glucosaminidase 0.11 mg/ml, ~-mannosidase 0.006 mg/ml. Digestion was carried out for 18 h at 37 °C. The reduction in titre of exoglycosidase-and mock-treated virions was determined as described above.
Immediately after preparation of the exoglycosidase enzyme mixture and after incubation of enzymes under assay conditions for 18 h, enzyme activity was assessed by the use of synthetic substrates. /~-Galactosidase, N-acetyl-fl-D-glucosaminidase and ~-mannosidase activity was determined by adding 10 p.l of the enzyme mixture to 990 ~tl of TBS-phosphate buffer (35 mM-Tris-HCl, 105 mM-NaCI, 50 mM-sodium phosphate, pH 6.0) containing 4 mM-4-nitrophenyl-/~-D-galactopyranoside, 4 mM-4-nitrophenyl-/~-D-glucopyranoside or 10 mM-4-nitrophenyl-/~-D-mannopyranoside, respectively. The reaction was allowed to proceed for 5 rain at 30 °C and stopped by addition of 2 ml stop solution (0.5 M-Na2CO3 pH > 12-0). Absorbance at 405 nm was measured against a blank not containing enzymes and the enzyme activity in mU/ml was calculated.
The activity of sialidase in the enzyme mixture was measured by adding 10 p.l of enzyme solution to 190 p.1 of TBS-phosphate buffer containing a final concentration of 0.125 mM-2-~-(4-methylumbelliferyl)-N-acetyl-Dneuraminic acid. The incubation period was 5 min at 37 °C and the reaction was stopped by adding 1.8 ml of 0.4 Mglycine-NaOH buffer pH 10-4. The sialidase activity was determined in a fluorescence spectrophotometer (excitation wavelength 312 nm, emission wavelength 455 nm) using a 5 nM-methylumbelliferon solution as standard.
Protease assay. The protease activity in the endo-and exoglycosidase preparations used in this study was determined according to the procedure proposed by Twining (1984) . Briefly, 25 p.1 fluorescein isothiocyanate (FITC)-labelled casein solution in 50 mM-Tris-HCl pH 7.2 [prepared essentially as described by Twining (1984) , protein content approx. 1 g/100 ml] was added to 10 ptl TBS and 10 ~tl endo-and/or exoglycosidase mixture, and was incubated for 18 h at 37 °C. Subsequently, the remaining FITC-casein conjugate was precipitated with 120 ~tl 5 ~ TCA overnight at 4 °C and pelleted for 10 min at 10 000g. A portion (60 p.1) of the supernatant was added to 400 p.1 of 0.5 M-Tris-HC1 buffer pH 8.5. Finally, the fluorescence of the supernatant was measured (excitation wavelength 492 nm, emission wavelength 518 nm) and the relative protease activity was calculated in virtual units.
Adsorption experiments. The adsorption of [3H]thymidine-labelled virions after treatment with endo-and exoglycosidases was measured. Virus suspensions were diluted to asp. act. of approx. 2 x l0 s c.p.m./ml in ice-cold BME, 0.05~ NAN3. To inhibit the turnover of membrane proteins and viral penetration, cells were also preincubated for 20 min at 4 °C in BME, 0.05 ~ NaN 3. Virus suspension (2 ml) was layered onto RC-37 cells in 5 cm Petri dishes. The sp. act. of virus input was determined by counting an aliquot of the input virus immediately after addition to the cell monolayer. After incubation periods of 5, 10, 15, 20, 30, 40 and 60 min dishes were carefully agitated and 50 ~tl aliquots of supernatants were taken to determine the remaining activity. Cells were washed simultaneously seven times with cold BME containing 0-05 ~o NaN3 and were harvested by agitation with glass beads. Cells were washed twice in cold BME, 0.05 ~ NAN3, were resuspended in 70 ~tl BME and mixed with 15 ml Aquasol (New England Nuclear) to determine bound radioactivity. The efficiency of the washing procedure was controlled by liquid scintillation counting of the respective washing buffer.
Competition between [3H]thymidine-labelled Endo-F-treated virions and mock-treated virions was examined as follows. Semi-confluent monolayers of RC-37 cells grown in 96-well fiat bottomed microtitre plates were washed twice with cold BME and incubated with BME containing 0-05 ~ NaN 3 for 20 min at 4 °C. Supernatants were then removed and [3H]thymidine-labelled Endo-F-treated virions (sp. act. 3.5 × 104 c.p.m.) and mocktreated virions (prepared as described above) were added (final volume 40 pl in BME, 0.05~ NAN3). Virus was allowed to adsorb for 60 min at 4 °C, ceils were washed with cold BME, 0.05 ~ NAN3, harvested and cell-bound radioactivity was determined as described above.
Gel electrophoresis and immunoblotting. Proteins were separated on discontinuous non-gradient SDSpolyacrylamide gels of 1.5 mm thickness [stacking gel: total acrylamide-bisacrylamide concentration (T) 4~, percentage bisacrylamide of T (C) 2.6~; separation gel: T 10~o, C 0.5~] cross-linked with N,N'-methylenebisacrylamide essentially as described by Thomas & Kornberg (1975) . Electrophoresis was carried out at 4 °C to a total of approx. 1200 volt hours.
Electroblotting of SDS-polyacrylamide gels was performed according to Towbin et al. (1979) and modified as described previously (Kiihn et al., 1987) . After transfer, nitrocellulose membranes Schleicher & Schiill) were blocked with 2~ bovine serum albumin (BSA) (Sigma) and 1 ~ non-fat dried milk powder in TBS for 2 h at 37 °C. After blocking, the filters were washed three times with TBS containing 0.5~ BSA and incubated with primary antibodies in TBS, 0.5~ BSA for 2 to 3 h at 37 °C or overnight at 4 °C. Re-isolated monospecific human antibodies were obtained as described below. The HSV-l-specific rabbit antiserum was purchased from Dakopatts, Hamburg, FR.G., and the HSV gB-monospecific rabbit antiserum was kindly provided by P. G. Spear, University of Chicago, Ill., U.S.A. Subsequently, filters were washed twice for 5 min at 37 °C with TBS, 0.5 ~o BSA and once for 10 min with TBS, 0-5 ~ BSA and allowed to react with the second antibody [horseradish peroxidase-conjugated F(ab')2 fragments of goat anti-human IgG or goat anti-rabbit/gG; Medac, Hamburg, F. R. G.] in TBS, 1% B SA, 0.5 % non-fat dried milk powder for 2 h at 4 °C. Finally, filters were washed twice for 10 min in TBS, 1% BSA at 37 °C and once for 15 min in TBS, 1~ BSA. All solutions used in immunoblotting procedures contained 0.01 ~ (w/v) merthiolate (Sigma) and 1 mM-PMSF. Membrane-bound peroxidase activity was visualized by adding substrate solution containing 0.5 mg/ml 4-chloro-l-naphthol (Sigma) and 0.03% (w/v) H20 z in TBS pH 7.4. The reaction was allowed to proceed until background staining developed.
Re-isolation ofmonospecific antibodies from immunoblots. To obtain monospecific antibodies directed against the major HSV glycoproteins, specifically bound antibodies were re-isolated from immunoblots as proposed by Olmsted (1981) and according to the procedure described previously (Norrild et al., 1985; Kiihn et al., 1988) . After electroblotting and incubation with the primary antibody, representative lanes were excised. After visualization of antibody reactivity the corresponding part of the remaining membrane containing specifically bound primary antibody was cut out, minced, and incubated with periodic agitation in 1.5 ml re-isolation buffer (0-1 M-glycine buffer pH 2.8, 2 M-NaCI) for 15 min. The supernatants were filtered through a 0.22 gm filter to remove remaining nitrocellulose particles, brought to a neutral pH by adding a small amount of 1 M-NaOH (approx. 30 gl) and stabilized by the addition of 325 gl of TBS, 5 % BSA. Finally, the solution was dialysed overnight at 4 °C against TBS. Antibody preparations were either used directly in immunoblots or stored at 4 °C after addition of 1 mM-PMSF, 0.01 ~ merthiolate.
RESULTS
Influence of exo-and endoglycosidase treatment on the infectivity of HSV-1
Stepwise digestion of oligosaccharide residues of purified intact HSV-1 Ang virions from their non-reducing termini with a combination of the four exoglycosidases sialidase, fl-galactosidase, N-acetylglucosaminidase and c~-mannosidase was found to decrease viral infectivity by 4.5 log10 units, as shown in Table 1 . When ~-mannosidase was omitted, the resulting titre reduction was 3 log10 units. Digestion with sialidase alone or in combination with fl-galactosidase, however, did not lead to any measurable reduction in titre (Table 1) . Determination of the proteolytic activity of the enzyme and virus preparations used, also shown in Table 1 , revealed considerable contamination of N-acetylglucosaminidase and ct-mannosidase with proteases. In general this proteolytic activity corresponded to the observed decrease of viral infectivity. However, digestion of virions with all exoglycosidases except sialidase did not lead to any obvious reduction in titre, indicating a resistance of intact virions to protease activity. This assumption was supported by the finding that addition of trypsin to purified virions, at a concentration resembling the protease contamination of the exoglycosidase preparations, led to a reduction of viral infectivity only in combination with simultaneous sialidase treatment (Table 1) . In contrast, a proteolytic activity in endoglycosidases Endo-H and Endo-F and in virions themselves could not be demonstrated. Whereas digestion with Endo-H did not lead to a measurable reduction in titre, treatment with Endo-F in all experiments led to a decrease in titre by a factor of 10 (Table 1) . Analysis of the various exoglycosidase-and endoglycosidase-treated virion preparations on sucrose gradients (data not shown) revealed a comigration of the enzyme-digested virus particles as compared to mock-treated controls. This finding indicates that the majority of treated particles was still physically intact, i.e. possessed envelopes.
To assess the effects of Endo-F digestion on attachment of virions to the cell surface we studied the kinetics of adsorption of [3H]thymidine-labelled Endo-F-digested virions to RC-37 cells in comparison to controls, as shown in Fig. 1 . In these experiments a difference between mock-digested virions (addition of enzyme after the incubation period) and Endo-F-digested virions could not be demonstrated, indicating that adsorption of virions lacking complex type glycosylation on the surface was not altered.
In addition, competition experiments between mock-digested and [3H]thymidine-labelled Endo-F-digested virions were carried out ( Table 2 ). The adsorption of Endo-F-treated virus could be effectively reduced by competition with mock-treated virus. Identical results were obtained in control experiments using [3H]thymidine-labelled mock-treated virions (data not shown). These findings demonstrate that the binding properties of Endo-F-treated virions were not altered in comparison to mock-treated virions.
Susceptibility of HSV-I glycoproteins of intact virions to enzymic deglycosylation
SDS-PAGE and immunoblot analyses were performed to examine the effects of exo-and endoglycosidase digestion on the major surface glycoproteins of HSV-1 Ang. Virus particles were digested under the conditions described above. As shown in Fig. 2 (a to d) treatment led to an increased mobility of gB, gE and gD, indicating removal of peripheral sialic acid residues from these proteins. Additional digestion with the exoglycosidases fl-galactosidase, N-acetylglucosaminidase and ~-mannosidase, however, did not lead to a further increase in the electrophoretic mobility of glycoproteins ( Fig. 2a to d, lanes 3 to 5) . In contrast, digestion with Endo-F led to a substantial decrease of the apparent Mr of all major glycoproteins ( Fig. 2a to d, lanes 7) . Thus, the apparent Mr ofgC and gB was reduced to approx. 100K, that of gE was reduced to approx. 70K and of gD to approx. 45K, which in the case of gB, gE and gD are values near the Mr of their known precursors. This indicates that all glycoproteins contain substantial amounts of N-linked complex type oligosaccharides which are susceptible, in intact virions, to Endo-F digestion. The combination of Endo-F with sialidase alone (data not shown) or in combination with the other exoglycosidases led to a further increase in electrophoretic mobility of all glycoproteins, which may demonstrate the presence of sialic acid residues on Olinked carbohydrate chains ( Fig. 2a to d, lanes 6 ). In contrast, cleavage of N-linked high mannose type oligosaccharides with Endo-H increased the electrophoretic mobility only of gB, showing that in intact virions none of the other major glycoproteins possesses significant amounts of high mannose type oligosaccharide chains ( Fig. 2a to d, lanes 10) . Furthermore, in these experiments a role of glycosylation in the resistance of gB to various proteases could be demonstrated. Treatment of virions for 18 h at 37 °C with 1.6 ~tg/ml trypsin, which corresponded to the proteolytic contamination found in the exoglycosidase mixture (Table 1) , did not result in any obvious degradation of gC, gB and gD, whereas gE apeared to be highly sensitive to trypsin digestion alone (Fig. 2a to d, lanes 8) . Incubation of virions with a combination of Endo-F and trypsin, however, led to a strong proteolytic cleavage of gB. In contrast, gC and gD were shown to be relatively resistant to combined Endo-F and trypsin treatment ( Fig. 2a to d, lanes 9 ).
Infectivity and glycoprotein composition of virions formed in the presence of tunicamycin
As the experimental approach described above resulted in the enzymic removal of N-linked oligosaccharides, but only of the peripheral sialic acid residues from O-linked oligosaccharides, virions were prepared from the supernatants of RC-37 cells grown in the presence of tunicamycin. This protocol was intended to yield preparations of virions completely lacking Nand O-linked glycosylation. Indeed we were able to purify apparently intact HSV-1 particles from supernatants of such cells, which in sucrose gradients had an identical sedimentation rate to standard virus (Fig. 3) . Further analysis in the electron microscope (Fig. 4a, b) revealed that approximately 95 ~o of these viral particles possessed envelopes. The majority of viral envelopes seemed to be morphologically intact. However, as calculated from [3H]thymidine incorporation the virus yield was only 7 ~ of that in a standard infection (Table 3) . Again, calculated from the relative [3H]thymidine incorporation, the specific infectivity of virions from cells treated with tunicamycin was 2.5 log10 units less than the infectivity of standard virus (Table 3) . Analysis of the glycoprotein composition of tunicamycin-treated virions revealed an almost complete lack of glycoproteins or their precursors in viral envelopes. Precursors of gC, gB, gD and gE, however, could be demonstrated in cell lysates from tunicamycin-and mock-treated cells (Fig.  5) . When immunoblots were heavily overloaded with viral proteins, minimal traces of glycosylated gB could be demonstrated in tunicamycin-treated viral particles (Fig. 5 b, lane 2) . This was probably due to a slight leakage of the tunicamycin block. In order to quantify the amount of gB in tunicamycin-treated virions, [3H]thymidine-labelled mock-treated virions and tunicamycin-treated virions were brought to equal specific activities, serially diluted, and analysed in Western blots for their reaction with the gB-monospecific rabbit antiserum (data not shown). In mock-treated virions gB could be still detected at a dilution of 1:50, whereas in tunicamycin-treated virions traces of gB were demonstrated only in the undiluted sample. It was therefore estimated that in tunicamycin-treated virions gB was reduced by approx. 50-fold. Taken together these data most probably indicate that the reduced infectivity of tunicamycintreated virions was a result of an altered glycoprotein composition of their envelopes rather than a direct effect of underglycosylation of glycoproteins. Using specific exo-and endoglycosidases we have analysed the effects of enzymic deglycosylation on the glycoproteins and infectivity of HSV-1 Ang. It was found that of the various exoglycosidases only sialidase had a measurable effect on the electrophoretic mobility of HSV glycoproteins, indicating that this was the only exoglycosidase that effectively removed the appropriate carbohydrate moieties. Sialidase treatment alone, however, did not result in any appreciable reduction of viral infectivity. This finding is in accordance to previous results of Serafini-Cessi et al. (1983) , who were unable to demonstrate an influence of modification of terminal sugars on the infectivity of HSV-1. Further stepwise digestion with fl-galactosidase, N-acetylglucosaminidase and ct-mannosidase led to a significant reduction in viral titres, but did not remove any significant amounts of carbohydrate from the major glycoproteins. As the latter enzymes had considerable protease contamination, it is conceivable that the observed reduction in titre could be attributed to proteolytic activity rather than to specific glycohydrolase activity. The reason for the lack of activity of the latter three enzymes on intact virions may be due either to a lack of accessibility of the respective substrates for the enzymes or to a different aglycon specificity than is present in HSV-1 Ang. A loss of the enzymic activity of fl-galactosidase is less likely, since the enzyme efficiently cleaved synthetic substrates under the assay conditions chosen. We cannot comment on the possible activity of N-acetylglucosaminidase and ct-mannosidase on HSV virions, as the activity of both of these enzymes is dependent on the prior removal of the peripheral galactose residues. Both enzymes, however, were fully active when tested with synthetic substrates.
Treatment of virions with Endo-H revealed a considerable amount of high mannose type glycosylation on gB, as previously described by Wenske et al. (1982) . The presence of high mannose type oligosaccharides on gB in intact virions may reflect a partial prevention of carbohydrate processing by dimerization (Claesson-Welsh & Spear, 1986) , as has been previously described for other proteins (Keil et al., 1984) . The infectivity of HSV-1 following Endo-H treatment was not significantly altered. In contrast, complex type oligosaccharides could be effectively removed from all four major glycoproteins by Endo-F, which probably reflects the broad specificity of the Endo-F preparation used for diantennary, triantennary and tetraantennary oligosaccharide chains (Tarentino et al., 1985) . The observed highly efficient cleavage of N-linked oligosaccharide chains from intact virions by both endoglycosidases was an unexpected result because, with few exceptions, oligosaccharide chains of glycoproteins in their native state have been reported to be inaccessible to cleavage enzymes (Tarentino et al., 1985) . The observed decrease in titre of 1 log10 unit caused by Endo-F digestion is most likely to indicate a functional relevance of N-linked oligosaccharides to the level of penetration. The adsorption kinetics and cell receptor specificity of Endo-F-treated particles was found to be unchanged when compared to mock-treated controls.
In accordance with our results, Svennerholm et al. (1982) and Spivack et al. (1982) showed that adsorption of virions modified by 2-deoxy-D-glucose and tunicamycin was apparently unchanged. The specific infectivity of these particles, however, was found to be greatly reduced. Comparing the effects of tunicamycin on HSV-1 Ang with Endo-F treatment of virions, we observed that even under tunicamycin treatment morphologically intact virions were formed and released into the supernatants of infected cells. In contrast to the situation with Endo-Ftreated virions, however, we were not able to demonstrate any glycoproteins or their precursors, except traces of fully glycosylated gB (approx. 1/50 the amount in standard virus), in envelopes of tunicamycin-treated virions. The addition of N-linked oligosaccharide chains (which is blocked by tunicamycin) may be thus a prerequisite for incorporation or stability of glycoproteins in viral envelopes but not for formation of viral envelopes themselves. In context with the data of Svennerholm et al. (1982) and Spivack et al. (1982) these data would further indicate that the major glycoproteins are dispensable for virus attachment but not penetration. Although complete processing of glycoproteins is not necessary for viral infectivity, as shown by Johnson & Spear (1982) , the presence of N-linked carbohydrates of either the complex or the high mannose type on HSV glycoproteins appears to be relevant for their function.
